Alnylam Pharmaceuticals
ALNY
#814
Rank
C$44.10 B
Marketcap
C$329.59
Share price
0.23%
Change (1 day)
-46.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company